Granny Smith

Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations

Retrieved on: 
Thursday, April 25, 2024
Cannabis, Retail, Other Consumer, Consumer, Other Retail, Natural Resources, Food, Beverage, Dark, Cream, Conversation, OCS, Pomegranate, International Financial Reporting Standards, SKU, Cannabinoid, Commitment, Limited, Supply, No Future, News, Stock, Health Canada, Lemonade, Financial statement, Result, Chocolate, Edible, Granny Smith, Consolidated, Ageing, CBN, Marotta, Blackberry, International, THC, Management, Research, Automation, EPS, Marketing, Snack, CBG, Sale, CBD, Patient, Analysis, Loss, Bank statement, Growth

"We are very pleased with our performance in the fourth quarter and fiscal year 2023, generating record net revenue, improved gross margins as well as record positive EBITDA and income from operations.

Key Points: 
  • "We are very pleased with our performance in the fourth quarter and fiscal year 2023, generating record net revenue, improved gross margins as well as record positive EBITDA and income from operations.
  • 35% of net revenue in Q4 2023 was derived from brands created and owned by Indiva including Indiva 1432 chocolate, Indiva Blips, Indiva Doppio Sandwich Cookies, and No Future gummies and vapes, up from 20% of net revenue in Q1 2023.
  • Gross revenue in Q4 2023 was a record $12.6 million, representing a 15.5% sequential increase from Q3 2023, and a 21.9% increase year-over-year from Q4 2022.
  • EBITDA was a record positive $1.6 million, or 4.2% of net revenue in 2023 versus a loss of $4.8 million in 2022.

Introducing Bobelo's Postbiotic Immunity with IMMUSE™ for the Whole Family

Retrieved on: 
Thursday, April 25, 2024
Stock, Health, CSCS, Taste, Research, Electrolyte, Granny Smith, Immune system, Vaccine

NEW YORK, April 25, 2024 /PRNewswire-PRWeb/ -- Kyowa Hakko U.S.A., Inc. and Bobelo have partnered to launch the all-new Postbiotic Immunity, a self-carbonating hydration drink that delivers comprehensive immune support. Created for health-conscious individuals and wellness enthusiasts, as well as members of their whole family, this innovative beverage stick pack is formulated with scientifically backed postbiotic IMMUSE™ to activate your body's natural defenses at the cellular level.

Key Points: 
  • We are thrilled to incorporate IMMUSE™ into our Bobelo Postbiotic Immunity.
  • Postbiotic Immunity is the first-ever drink stick pack with real carbonation and patented hydrating bubbles, making your new favorite healthy drink accessible on the go.
  • What sets the Bobelo Postbiotic Immunity apart is its inclusion of IMMUSE™, which activates the body's natural immune responses at the cellular level.
  • According to Stephen Colvin, founder of Bobelo, "We are thrilled to incorporate IMMUSE™ into our Bobelo Postbiotic Immunity.

Cannabis Innovator Lehua Brands Introduces New Products for Wellness-Minded and Experienced Consumers

Retrieved on: 
Wednesday, March 20, 2024
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Pesticide, Pomegranate, CBN, Granny Smith, Multimedia, THC

Lehua Brands , a California-licensed manufacturer of award-winning cannabis products, today announced a product line expansion with new brands crafted to provide high quality, healthier and function-based options for consumers in California and Canada.

Key Points: 
  • Lehua Brands , a California-licensed manufacturer of award-winning cannabis products, today announced a product line expansion with new brands crafted to provide high quality, healthier and function-based options for consumers in California and Canada.
  • Lehua Brands’ new offerings address this evolution with products in a variety of formats, all made with the finest-quality ingredients, with health and functionality at the forefront.
  • “Lehua is focused on driving the industry forward with a variety of innovative products that provide retailers with exciting options to meet consumers where they are.”
    The new brands within the growing Lehua portfolio include:
    Live ORO oral concentrate (1:1 / 10mg CBN: 10mg THC).
  • Lehua products are available in 115+ California licensed retailers and in April they will debut in Ontario, Canada.

The Hemp Doctor's Smokable and Edible Holiday Bundles Are Now On Sale

Retrieved on: 
Wednesday, December 20, 2023
Active ingredient, Delta, Holiday, Tropical fruit, Farm, Hemp, Granny Smith, Watermelon, THCA, Raspberry, Policy

MOORESVILLE, N.C., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The Hemp Doctor, one of America's leading online retailers and wholesalers of CBD and other hemp-derived products, has announced the launch of two discounted Holiday Bundles. Customers who purchase these bundles can save 25% on some of the company's most popular premium smokeable and edible products.

Key Points: 
  • Customers who purchase the Holiday Edible Bundle have their choice of flavors for the included Kayo Rapid Release Gummies.
  • "The products included in our Holiday Bundles include some of our customers' favorites as well as the prerolls from our new THCa product line," says The Hemp Doctor's Owner, Cindy Shade.
  • The Hemp Doctor will also be running 5th Anniversary Sales on its retail and wholesale websites starting December 26th and December 28th, respectively.
  • The Hemp Doctor products are Made in the U.S.A., and shipping time is typically one to five days.

Wyld Introduces New Sour Tangerine Hybrid-Enhanced Gummies

Retrieved on: 
Wednesday, October 18, 2023
CBC, Cannabis, Pomegranate, Climate, Granny Smith, Food preservation, Sours

CLACKAMAS, Ore., Oct. 18, 2023 /PRNewswire/ -- Wyld, one of the top five cannabis brands in the U.S., known for their best-selling cannabis infused edibles, is expanding their sour gummy product line with a Hybrid-enhanced sour tangerine gummy.

Key Points: 
  • Wyld first introduced their sour gummies in May of 2022 with Sour Cherry Indica-enhanced and Sour Apple Sativa-enhanced.
  • The Sour Tangerine gummy rounds out the Wyld Sours collection with the addition of a Hybrid-enhanced product.
  • "We're excited to launch our Sour Tangerine gummy and expand our Sours line as we continue to grow across the country," said Aaron Morris, Wyld CEO and co-founder.
  • The introduction of the sour tangerine gummy into Wyld's line up brings the total number of flavors to 12: elderberry, huckleberry, marionberry, raspberry, pomegranate, blood orange, peach, pear, strawberry, sour cherry, sour apple, and now, sour tangerine.

Indiva Reports Second Quarter 2023 Results

Retrieved on: 
Tuesday, August 29, 2023
Cannabis, Retail, Health, Natural Resources, General Health, Food, Beverage, Dark, Cream, Cannabis Act, Citrus, Marketing, International Financial Reporting Standards, Analysis, Management, Ageing, Supply, News, Automation, Lozenge, Edible, Pomegranate, FINANCIAL, No Future, OCS, Research, CBG, CBN, Limited, Growth, THC, International, Commitment, Financial condition report, Granny Smith, SKU, CBD, Farley's & Sathers Candy Company, Result, Bank statement, Cannabinoid, Health Canada, Conversation, Stock, Sale, EBITDA, Cryptocurrency, Gasoline, Pharmaceutical industry, Oil, Security (finance), Silviculture, Fine chemical, Doppio, Q2, Indiva, Pearl, Canopy

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the second fiscal quarter ended June 30, 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the second fiscal quarter ended June 30, 2023.
  • Gross revenue in Q2 2023 was $8.1 million, representing a 21.6% sequential decrease from Q1 2023, and an 8.5% decrease year-over-year from Q2 2022.
  • Data from Hifyre Inc. for the second quarter of 2023 shows strong sell-through of Indiva's edible products.
  • Baked Goods: Indiva led the baked goods category with 67.0% sub-category share, driven by the success of Doppio, formerly Indiva Life Double-Stuffed Sandwich Cookies.

Indiva Reports First Quarter 2023 Results

Retrieved on: 
Tuesday, May 16, 2023
Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Food, Beverage, Cannabis, Retail, Dark, Cream, Edible, Pomegranate, Citrus, International, FINANCIAL, Result, Classification, Marketing, Bank statement, Chocolate, Financial condition report, Cannabinoid, Health Canada, Conversation, OCS, Research, CBG, Sale, Granny Smith, CBN, Limited, EBITDA, Cannabis and impaired driving, Patient, International Financial Reporting Standards, Risk, Analysis, SEDAR, CBD, Management, Growth, Ageing, THC, Three Months, News, Automation, Legislation, Cryptocurrency, Fine chemical, Pharmaceutical industry, Oil, Maple syrup, Security (finance), Pearl, Tilray, Indiva

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.
  • Baked Goods: Indiva led the baked goods category with 61.0% sub-category share, driven by the success of Indiva Life Double-Stuffed Sandwich Cookies.
  • Product ranking in Q1 2023 showed two of the Top 10 edible SKUs are from Indiva.
  • OPERATING AND FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022

Indiva Reports Record Fiscal Year 2022 Results

Retrieved on: 
Tuesday, April 18, 2023
Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Food, Beverage, Cannabis, Retail, Melon, Midnight, Cream, Classification, Marketing, Sandwich, Wild cherry, TWELVE, Patient, Analysis, Ageing, Health Canada, News, Bhang, Automation, Edible, Pomegranate, Lemonade, FINANCIAL, Research, CBG, CBN, Limited, SEDAR, Growth, Consolidated, THC, Legislation, Loss, International, Financial condition report, Financial statement, Capsule, Granny Smith, CBD, Result, Bank statement, Cannabinoid, Stock, EBITDA, White chocolate, Sunset, Dime, Cryptocurrency, Pharmaceutical industry, Video game, Dietary supplement, Tea, Candy, Security (finance), Medical device, Oil, Indiva, Vanilla, Pearl, Tilray

Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.

Key Points: 
  • Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.
  • “We are pleased to report record revenue and record gross profit for the fiscal year 2022.
  • In 2022, Indiva introduced several new products from in-house innovation under the Indiva Life brand including Lozenges, Chocolates, Capsules and Sandwich Cookies.
  • Indiva also led the baked goods category with 49.6% sub-category share which includes recently launched Indiva Life Double-Stuffed Cookies.

The Hemp Doctor Launches Kayo Rapid Release Gummies, a Revolutionary Nano-Emulsified Gummy

Retrieved on: 
Friday, April 14, 2023
Cannabis, Granny Smith, CBN, THCV, Cannabinoid, Nano, CBC, CBG, Delta

"We are thrilled to introduce Kayo Rapid Release Gummies to our customers," said Robert Shade, Founder of The Hemp Doctor.

Key Points: 
  • "We are thrilled to introduce Kayo Rapid Release Gummies to our customers," said Robert Shade, Founder of The Hemp Doctor.
  • We believe that Kayo Rapid Release Gummies are a game-changer in the hemp industry, offering a new and highly effective way to experience the benefits of hemp."
  • All of The Hemp Doctor's products, including Kayo Rapid Release Gummies, are made using premium hemp and are third-party lab tested for purity and potency.
  • Kayo Rapid Release Gummies are now available for purchase on The Hemp Doctor's website, and orders are shipped nationwide.

Indiva Reports Third Quarter 2022 Results

Retrieved on: 
Tuesday, November 22, 2022
Women, Seniors, Other Retail, Cannabis, Men, Specialty, Food, Beverage, Consumer, Retail, Natural Resources, Melon, Midnight, Cream, CBN, Granny Smith, Marketing, International, Limited, Financial result, Growth, Ontario Cannabis Retail Corporation, SKU, Lemonade, Result, CBD, News, Raspberry, Edible, Research, Financial condition report, THC, Stock, Cannabinoid, Automation, Ageing, Sunset, Chocolate, White chocolate, Sunrise, Milk, Capsule, SEDAR, Farley's & Sathers Candy Company, CBG, Analysis, Pomegranate, OCS, Budtender, Zen, EBITDA, Pharmaceutical industry, Video game, Warehouse, Oil, Baking, Maple syrup, Candy, Coffee, Indiva, Vanilla, Dime

Indiva Limited (the Company or Indiva) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the third fiscal quarter ended September 30, 2022.

Key Points: 
  • Indiva Limited (the Company or Indiva) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the third fiscal quarter ended September 30, 2022.
  • In the third quarter, Indiva launched a record number of SKUs, primarily into the province of Ontario and B.C.
  • Gross revenue in Q3 2022 was $8.8 million, representing a 1.1% sequential decrease from Q2 2022, and a 5.9% increase year-over-year from Q3 2021.
  • Data from Hifyre Inc. for the third quarter of 2022 shows strong sell-through of Indiva edible products.